Myriad Genetics Inc (NASDAQ:MYGN)

Delayed Data
As of Sep 22
 -0.15 / -0.89%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 22.50, with a high estimate of 27.00 and a low estimate of 13.00. The median estimate represents a +35.38% increase from the last price of 16.62.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.56%
Growthannually -7.78%


Growthquarterly -1.69%
Growthannually 9.39%
Key to the earnings and sales forecast charts.